Menu
Make more informed health decisions throughout life with MyOme Personal Genome. One sample provides insights into disease and medication response risk informed by your entire genome.1
Disease Prevention
Early Detection
Medication Management
We provide a more complete picture of your disease risk through clinical-grade whole genome sequencing (30x coverage) and analysis–10 times more information than other tests–including rare and common variants and structural alterations.
Your genetic testing needs change over time. The MyOme Personal Genome platform enables you to receive on-demand health insights at every stage – from family planning to disease-risk information.
MyOme Personal Genome keeps up with the advances and understanding of biology. Our platform utilizes cutting-edge technologies, including machine learning and AI, so you can take advantage of new clinical research findings as they happen.
This report identifies mutations in 81 genes known to result in conditions such as cancers, heart disease, metabolic conditions and others. These are deemed actionable findings by the American College of Medical Genetics and Genomics (ACMG).
This report summarizes known variants in 15 genes associated with response to medications that may be used by an independent healthcare provider to optimize your care.
Most genetic tests analyze a panel of single genes that impact only 8% of people.2 The MyOme Personal Genome risk reports provide risk assessments for everyone. These reports combine an analysis of your genome—not just a panel of genes—coupled with clinical risk factors to provide a personal risk score for a particular condition.
Example of a Coronary Artery Disease (CAD) Integrated Personal Risk Score Report
This report provides a single risk score that integrates genetics with clinical factors to assess risk for coronary artery disease (CAD), for those those who may be missed by clinical evaluation (whereas traditional genetic panels evaluate rare genes impacting a small percent and without assessing CAD risk).
MyOme Personal Genome members will be automatically notified.
MyOme Personal Genome members will be automatically notified.
Submit your order via our secure online portal. A healthcare provider will review and if determined appropriate for you, will order your test.
Provide your sample right from home in the sample collection kit.
Access your first reports in the online portal. Genetic counseling is available.
Access new reports for a low cost as they are added to the platform to stay informed on advances in clinical research.
At MyOme, your data is yours. You can request your DNA data anytime, and we never sell or share your data without your permission. In addition, our platform is HIPAA-compliant and features enterprise-scale data encryption.
MyOme Personal Genome provides complimentary access to genetic counseling to help you understand your results and identify the next steps for your health.
MyOme Clinical Test | Other Genetic Screening Tests5 | |
|---|---|---|
Whole-genome Based Approach | 98% Yes, we sequence over 3,000,000,000 bases | ~0.2% No, they examine or sequence less than 900,000 bases |
New Reports | Our whole-genome approach allows for lifelong genetic analyses as research evolves | No, their data is incomplete |
Clinically Relevant | Yes, our reports focus on clinical risk where there’s clear actionability | Limited clinical utility with a focus on other areas, such as ancestry |
Re-Interpreted Data | Yes, because we sequence your genome, your reports can be updated with the latest scientific findings | No, their data is limited to what they initially examined |
Physician Ready | Yes, we provide a clinical report signed by a certified laboratory director ready to act on | Limitations of how they analyze your genome mean additional testing will likely be required |
Privacy | We will never sell your data without your consent and we abide by industry leading security protocols | Lack of transparency into how they might use your data |
Genetic Counseling | We offer post-report genetic counseling through our partners | Not always available and often at an additional charge |
MyOme Clinical Test | Other Genetic Screening Tests4 |
|---|---|
Whole-genome Based Approach | |
98% Yes, we sequence over 3,000,000,000 bases | ~0.2% No, they examine or sequence less than 900,000 bases |
New Reports | |
Our whole-genome approach allows for lifelong genetic analyses as research evolves | No, their data is incomplete |
Clinically Relevant | |
Yes, our reports focus on clinical risk where there’s clear actionability | Limited clinical utility with a focus on other areas, such as ancestry |
Re-Interpreted Data | |
Yes, because we sequence your genome, your reports can be updated with the latest scientific findings | No, their data is limited to what they initially examined |
Physician Ready | |
Yes, we provide a clinical report signed by a certified laboratory director ready to act on | Limitations of how they analyze your genome mean additional testing will likely be required |
Privacy | |
We will never sell your data without your consent and we abide by industry leading security protocols | Lack of transparency into how they might use your data |
Genetic Counseling | |
We offer post-report genetic counseling through our partners | Not always available and often at an additional charge |
What does establishing a MyOme Personal Genome account let me do?
Registering on the MyOme portal will enable you to request a test, track the status of your order and view / download your results and connect with a genetic counselor. Additionally, by being a registered user, you will be among the first to learn about new MyOme tests and reports. You can register for the portal here.
How old do I need to be to take the test?
You must be at least 18 years of age to request the MyOme Personal Genome test.
How does MyOme protect my data?
Your privacy and data security are important to us. We adhere to industry best practices in making sure your data is secure, easily accessible by you and is not used without your consent.
Can I order a test if I’m outside of the U.S.?
Currently, the MyOme Personal Genome test is only available to patients within the U.S.
How long does it take to get my test results?
For first-time tests, please anticipate 6-8 weeks for your results to be returned once we receive your sample at our lab.
What factors impact an individual’s response to medication?
An individual’s response to medication can be impacted by their physical characteristics (weight, sex, age), their lifestyle (diet, exercise levels), their overall health (other diseases, kidney/liver issues), their genetics, and other medications or supplements they take. Your healthcare provider will consider these factors when determining what medication is best for you.
Should I change my medication based on this report?
You should always consult your healthcare provider prior to making any changes to your medication regimen. Whenever a drug is prescribed, your healthcare provider weighs the benefits and risks associated with that prescription. Your genetics are only one piece of that decision process.
How is MyOme’s test different from other genetic tests?
MyOme performs genome sequencing to provide a more comprehensive picture of your health. As our understanding of genetics increases, MyOme is capable of updating your health report by reanalyzing your entire DNA without needing another sample. MyOme must be ordered by a healthcare provider to ensure you are guided by appropriate medical care with your results. Additionally, the MyOme Personal Genome test report is clinically actionable, which means you can share with your providers to manage your health.
Will genetic testing impact my health insurance or life insurance?
The Genetic Information Nondiscrimination Act (GINA) protects patients from certain types of genetic discrimination, such as health insurance eligibility or coverage. To learn more, please visit ginahelp.org.
What additional reports will Myome have in the near future?
See our future reports page.
How can I schedule a consultation with a genetic counselor?
MyOme has partnered with DNAvisit to provide complimentary genetic counseling consultations for each order.
You will be able to schedule your complimentary session with DNAvisit once your test reports are available. In certain circumstances, you will receive a direct email from DNAvisit. Otherwise, you will receive a prompt when downloading your results in your portal.
Should I share my test report with my healthcare provider? Will they be able to understand them?
Yes. Your genome in combination with other clinical risk factors, provides valuable insights into your health. Sharing this information with your healthcare provider can enable them to have a deeper understanding of your health and work with you to address accordingly.
Is the MyOme Personal Genome covered by insurance?
The MyOme Personal Genome is a screening test. Currently, it is not covered by insurance. Because the test is ordered by a licensed healthcare provider, there is no sales tax. You can use HSA and FSA funds towards the MyOme Personal Genome test.
What methods of payment do you accept for the MyOme Personal Genome?
We accept all major credit cards for payment.
How much will additional test reports cost?
As more reports are added to the MyOme Personal Genome platform, patients who have already ordered an initial test will have low-cost, timely access to these reports.
1. NIH, Congressional Rare Disease Act
2. Shiovitz S, Korde LA. Genetics of breast cancer: a topic in evolution. Ann Oncol. 2015 Jul;26(7):1291-9. doi: 10.1093/annonc/mdv022. Epub 2015 Jan 20. PMID: 25605744; PMCID: PMC4478970.
3. Shiovitz S, Korde LA. Genetics of breast cancer: a topic in evolution. Ann Oncol. 2015 Jul;26(7):1291
4. Tshiaba, P., et al. Improved Breast Cancer Risk Stratification by Integration of a Cross-ancestry Polygenic Model with Clinical Risk Factors # PB3447 Presented at the Annual Meeting of The American Society of Human Genetics, October 27, 2022, Los Angeles
5. Saey, Tina Hesman. “What Genetic Tests like 23andMe Actually Told Me about My Health.” Science News, 21 Aug. 2019, www.sciencenews.org/article/review-genetic-tests-23andme-veritas-genos-health-comparison
*In some cases, an additional sample may be required
